Today: 4 June 2026
Browse Category

NASDAQ:CNFL 30 March 2026

IBM Stock Rises, but AI Bet and Q4 Beat Still Can’t Shake Selloff Fears

IBM Stock Rises, but AI Bet and Q4 Beat Still Can’t Shake Selloff Fears

IBM shares rose 0.4% Monday but remain nearly 27% below their 52-week high after a sharp early-year selloff. The company completed its $11 billion Confluent acquisition on March 17 and will report first-quarter results April 22. IBM stopped disclosing standalone AI revenue, removing a key metric for investors. Bank of America reiterated a Buy rating and $340 target on March 10.
30 March 2026
····

Stock Market Today

  • 3 Stocks Outperforming Nvidia in 2026: Nebius, Micron, TSMC
    June 4, 2026, 1:30 PM EDT. Nvidia's AI-focused stock rose 15% in 2026 but trails behind three top performers: Nebius, Micron Technology, and Taiwan Semiconductor Manufacturing Company (TSMC). Nebius, a neocloud company specializing in AI cloud computing, surged 149% with Q1 revenue up 684% year-on-year, targeting an annual run rate of $7-$9 billion by year-end. Micron, a memory chip maker critical for GPUs, is benefiting from a chip shortage driving revenue and a potential market expansion from $35 billion in 2025 to $100 billion by 2028. Its stock trades at a forward price-to-earnings ratio of 16, reflecting cyclical risk but room for growth. TSMC also outpaces Nvidia, contributing to the semiconductor sector's momentum.

Latest articles

AT&T falls as SpaceX threat renews broadband concerns

AT&T falls as SpaceX threat renews broadband concerns

4 June 2026
AT&T shares plunged 3.7% to $22.69 after Oppenheimer downgraded the stock, warning SpaceX’s Starlink could disrupt the $1.6 trillion U.S. communications market and threaten broadband and mobile subscriber growth; the drop came as the Supreme Court upheld FCC fines against AT&T and as SpaceX moves toward a public listing, intensifying investor focus on broadband competition.

Nu Holdings Up After $1 Billion Buyback Plan, Analysts Cautious

4 June 2026
Shuttle Pharmaceuticals shares slid 3.2% to $0.507 as investors questioned its abrupt pivot from cancer-drug development to Dogecoin and Litecoin mining, with the stock trading well below the $1.03–$1.24 conversion prices in recent merger and financing deals and the company warning of substantial doubt about its ability to continue as a going concern.
High demand wipes out U.S. Mint $5,370 gold coin in minutes

High demand wipes out U.S. Mint $5,370 gold coin in minutes

4 June 2026
The U.S. Mint’s new $5,370 one-ounce American Eagle gold coin sold out in under two minutes, highlighting surging demand for physical gold investment, which Metals Focus says will overtake jewelry as the top gold demand driver this year; spot gold rose 1.7% to $4,505.35, but analysts warn high rates and a stronger dollar could pressure prices and premiums.
Recursion Stock Jumps Before Goldman Sachs Event as AI-Drug Trade Gets Fresh Heat

Recursion Stock Jumps Before Goldman Sachs Event as AI-Drug Trade Gets Fresh Heat

4 June 2026
Recursion shares surged about 12% to $3.87 on heavy volume ahead of its June 9 Goldman Sachs healthcare conference appearance, as investors look for updates on clinical timing, cash runway, and partnerships; small insider-sale filings were disclosed, and the move comes amid a broader rally in healthcare and AI drug-discovery stocks.
Go toTop